Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(4.80)
# 107
Out of 5,008 analysts
21
Total ratings
85.71%
Success rate
34.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Maintains: Buy | $70 → $110 | $57.92 | +89.92% | 4 | Oct 6, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $40 | $3.67 | +989.92% | 2 | Oct 1, 2025 | |
| HRMY Harmony Biosciences Holdings | Maintains: Buy | $70 → $55 | $27.05 | +103.33% | 1 | Sep 25, 2025 | |
| ATAI Atai Life Sciences | Reiterates: Buy | $15 | $5.54 | +170.76% | 1 | Sep 23, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.14 | +1,359.14% | 1 | Sep 16, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $15 | $5.66 | +165.02% | 1 | Sep 15, 2025 | |
| BEAM Beam Therapeutics | Reiterates: Buy | $80 | $25.13 | +218.34% | 1 | Sep 15, 2025 | |
| VYGR Voyager Therapeutics | Reiterates: Buy | $30 | $4.73 | +534.25% | 1 | Sep 15, 2025 | |
| DRUG Bright Minds Biosciences | Reiterates: Buy | $85 | $50.83 | +67.22% | 2 | Sep 15, 2025 | |
| ALGS Aligos Therapeutics | Reiterates: Buy | $50 | $9.75 | +412.82% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.70 | +1,333.08% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $570 | $459.58 | +24.03% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $36.54 | +118.94% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.63 | +206.75% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.94 | +68.35% | 1 | Aug 18, 2025 |
uniQure
Oct 6, 2025
Maintains: Buy
Price Target: $70 → $110
Current: $57.92
Upside: +89.92%
NRx Pharmaceuticals
Oct 1, 2025
Reiterates: Buy
Price Target: $40
Current: $3.67
Upside: +989.92%
Harmony Biosciences Holdings
Sep 25, 2025
Maintains: Buy
Price Target: $70 → $55
Current: $27.05
Upside: +103.33%
Atai Life Sciences
Sep 23, 2025
Reiterates: Buy
Price Target: $15
Current: $5.54
Upside: +170.76%
Silence Therapeutics
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $5.14
Upside: +1,359.14%
Vir Biotechnology
Sep 15, 2025
Reiterates: Buy
Price Target: $15
Current: $5.66
Upside: +165.02%
Beam Therapeutics
Sep 15, 2025
Reiterates: Buy
Price Target: $80
Current: $25.13
Upside: +218.34%
Voyager Therapeutics
Sep 15, 2025
Reiterates: Buy
Price Target: $30
Current: $4.73
Upside: +534.25%
Bright Minds Biosciences
Sep 15, 2025
Reiterates: Buy
Price Target: $85
Current: $50.83
Upside: +67.22%
Aligos Therapeutics
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $9.75
Upside: +412.82%
Sep 4, 2025
Reiterates: Buy
Price Target: $10
Current: $0.70
Upside: +1,333.08%
Sep 2, 2025
Reiterates: Buy
Price Target: $570
Current: $459.58
Upside: +24.03%
Sep 2, 2025
Reiterates: Buy
Price Target: $80
Current: $36.54
Upside: +118.94%
Aug 27, 2025
Reiterates: Buy
Price Target: $5
Current: $1.63
Upside: +206.75%
Aug 18, 2025
Reiterates: Buy
Price Target: $10
Current: $5.94
Upside: +68.35%